epocrates logo
epocrates logo
epocrates logo
  • 0

Journal Article Synopsis

JAMA Netw Open

Early ADHD treatment may reduce nicotine use among youths

February 14, 2025

card-image

Study details: This longitudinal cohort study followed 13,572 U.S. youths aged 12 to 17 years over a 9-year period using data from the Population Assessment of Tobacco and Health Study. The study aimed to evaluate the association between ADHD diagnosis, symptom severity, pharmacotherapy, and the onset of e-cigarette and tobacco use.

Results: Youth with ≥3 ADHD symptoms had significantly higher adjusted odds of initiating e-cigarette use, cigarette smoking, other tobacco use, and dual use (1.60, 1.52, 1.61, and 1.72, respectively) compared with those with asymptomatic ADHD or population controls. The association was consistent regardless of pharmacotherapy status.

Clinical impact: Early diagnosis and management of ADHD may reduce the risk of subsequent nicotine and tobacco use among adolescents. Consider comprehensive ADHD treatment plans that address both behavioral and pharmacological aspects to mitigate these risks.

Source:

McCabe SE, et al. (2025, February 3). JAMA Netw Open. Attention-Deficit/Hyperactivity Disorder Symptoms and Later E-Cigarette and Tobacco Use in US Youths. https://pubmed.ncbi.nlm.nih.gov/39932711/

learn more about epocrates plus

Clinical FAQs

Check out the answers to frequently asked questions about our clinical content.

Download Epocrates from the App StoreDownload Epocrates from the Play Store
About UsFeaturesBusiness SolutionsHelp & FeedbackCookie Preferences
© 2026 epocrates, Inc.   Terms of UsePrivacy PolicyEditorial PolicyDo Not Sell or Share My Information